TrialAntimicrobial agents and chemotherapy2013

Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Rose M Viscardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.